App-Quantinova.ai

The Impact of Cold Ischaemia Time on Living Donor Kidney Transplantation Outcomes

S. C. van de Laar - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The New UK National Kidney Allocation Scheme with Maximized ‘D4/R4’ Kidney Transplants: Appropriate Donor to Recipient Matching or System Overstretch?

R. Pearson - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Cytomegalovirus infection

N/A

Thymoglobulin (ATG) Induction vs. Campath vs. Simulect in DCD Kidneys in UK; Induction Regimes Play a Role after All

A. Asderakis - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Transplant rejection

Simulect

Third and Fourth Kidney Re-Transplants: A 20-Year Single Centre Experience

O. O. Okidi - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Transitional B Cell Cytokines for the Early Prediction of Long-Term Renal Allograft Decline

A. Cherukuri - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Transplant rejection

Simulect

UK Residents Transplanted Overseas: A Summary of UK Data from 2000-2016

A. Cronin - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Low Dose versus Standard Dose Alteplase in Acute Lacunar Ischemic Stroke

Zien Zhou - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

Activase I.V.

Intracerebral Hemorrhage Across the United States

Augustin DeLago - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Global Impact of the Covid-19 Pandemic on Subarachnoid Hemorrhage

Thanh N Nguyen - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Subarachnoid hemorrhage

N/A

Reduction in Ischemic Stroke With Icosapent Ethyl - Insights From REDUCE-IT

Deepak L Bhatt - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

Icosapent ethyl

Declining Morbidity From Subarachnoid Hemorrhage in the Last 4 Decades

Sean Neifert - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Subarachnoid hemorrhage

N/A

SPAK/OSR1 Signaling as a Novel Target for Post-Stroke Oxidative Stress Brain Injury

Jun Wang - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemia-reperfusion injury

Hydrogen peroxide

Incidence, Characteristics and Outcomes of Large Vessel Stroke in Covid-19

Priyank Khandelwal - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronavirus disease

N/A

Impact of the Covid-19 Pandemic on Stroke Thrombolysis Rate and Delay to Thrombolysis Treatment in a Regional Stroke Centre in London, UK

Brian Drumm - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronavirus disease

N/A

Economic and Clinical Model for Direct Transfer to Angiosuite Protocol Development

Manuel Requena - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Developing Automated Methods for Disease Subtyping in UK Biobank

Kristiina Rannikmae - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Reversible Relative FLAIR Signal Intensity Changes in the Penumbra Correlate With Severity of Hypoperfusion

Lauranne Scheldeman - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Hospital Management of Major Stroke Types in Urban and Rural China

Haiqiang Qin - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Identification of Traumatic and Non-Traumatic Intracranial Bleeding Subtypes in Patients With Non-Valvular Atrial Fibrillation Receiving Oral Anticoagulant Therapy Using Primary Care Data From the United Kingdom

Luis A Garcia Rodriguez - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Non-valvular atrial fibrillation

N/A

Postoperative Cerebrovascular Accident Following Symptomatic Carotid Endarterectomy (OSTIUM) A Retrospective Case-Control Study

Jack Hood - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Filters

45280 Abstracts